ATXI · Avenue Therapeutics, Inc. · Analyst Estimates
$0.38
-0.05 (-10.71%)
At close · Mar 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, as described below, substantial doubt about the Company’s ability to continue as a going concern exists. These factors individually and collectively cause substantial doubt about the Company’s ability to continue as a going concern to exist within one year from the date of this report.”View the 10-Q filed Nov 6, 2026
Market Cap
$848,783
Shares
3.29M
Volume · Mar 19
173.84K
Avg daily vol (3M)
426.7K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Avenue Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-14 07:34 UTC · Publication dates shown per estimate · 2 metric / period groups
FY ending 2024-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
analysts
Publication date not stated |
— | — | — |
0
|
Q ending 2024-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
analysts
Publication date not stated |
— | — | — |
0
|